title: Breast MRI using a high-relaxivity contrast agent: an overview.
abstract: OBJECTIVE
  The purpose of this article is to review the use of gadobenate dimeglumine, a high-relaxivity gadolinium-based contrast material, for breast MRI.
  
  
  CONCLUSIONS
  Thanks to its high relaxivity, gadobenate dimeglumine offers valuable advantages in terms of lesion conspicuity, detection rate, and sensitivity for malignant breast lesions. However, a higher enhancement of benign lesions should be taken into account to avoid reduced specificity.
authors.affiliation: Unit of Radiology, IRCCS Policlinico San Donato, San Donato Milanese, Milano, Italy.
authors.forename: Luca A
authors.initials: LA
authors.lastname: Carbonaro
authors.forename: Federica
authors.initials: F
authors.lastname: Pediconi
authors.forename: Nicola
authors.initials: N
authors.lastname: Verardi
authors.forename: Rubina M
authors.initials: RM
authors.lastname: Trimboli
authors.forename: Massimo
authors.initials: M
authors.lastname: Calabrese
authors.forename: Francesco
authors.initials: F
authors.lastname: Sardanelli
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis*; D003287:Contrast Media / Q000737:chemistry; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008536:Meglumine / Q000031:analogs & derivatives* / Q000737:chemistry; D009942:Organometallic Compounds / Q000737:chemistry; D012680:Sensitivity and Specificity
chemical_list: D003287:Contrast Media; D009942:Organometallic Compounds; C064572:gadobenic acid; D008536:Meglumine